Cargando…
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
PURPOSE OF REVIEW: To highlight the added benefits of approved and upcoming, centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and cardiovascular effects but also on their less explored clinical benefits and drawbacks, in order to provide clinicians with a tool for...
Autores principales: | Guglielmi, Valeria, Bettini, Silvia, Sbraccia, Paolo, Busetto, Luca, Pellegrini, Massimo, Yumuk, Volkan, Colao, Anna Maria, El Ghoch, Marwan, Muscogiuri, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250472/ https://www.ncbi.nlm.nih.gov/pubmed/37209215 http://dx.doi.org/10.1007/s13679-023-00502-7 |
Ejemplares similares
-
Personalized Nutritional Strategies to Reduce Knee Osteoarthritis Severity and Ameliorate Sarcopenic Obesity Indices: A Practical Guide in an Orthopedic Setting
por: Zmerly, Hassan, et al.
Publicado: (2023) -
Editorial: Covid-19 and obesity
por: Guglielmi, Valeria, et al.
Publicado: (2022) -
Why should sarcopenic obesity be included in a routine assessment during weight-management programmes?
por: El Ghoch, Marwan, et al.
Publicado: (2022) -
Mediterranean Diet and Obesity-related Disorders: What is the Evidence?
por: Muscogiuri, Giovanna, et al.
Publicado: (2022) -
The Fat Kidney
por: Verde, Ludovica, et al.
Publicado: (2023)